Journal of CME (05/08/26) Robinson, Katie; Lester, Kevin; Persaud, Sasha; et al.

Researchers evaluated a comprehensive continuing education (CE) curriculum designed to increase ophthalmologists’ adoption of second-generation intravitreal anti-VEGF therapies for diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD). The program used 14 multimodal activities — including didactic content, case scenarios, live meetings, interprofessional activities and downloadable resources — from July 2024 to April 2026. Among 398 providers with complete data, both those who completed a single activity and those who completed three or more activities showed improved knowledge and comfort with newer anti-VEGF agents. Multiple-activity learners began with higher baseline knowledge and more frequently selected second-generation therapies in case scenarios, while single-activity learners demonstrated larger knowledge gains. The program also enhanced preparedness for future therapies, particularly among low-frequency injectors, despite some remaining adoption barriers, indicating that iterative, data-driven CE can effectively accelerate integration of emerging treatments into real-world DME and nAMD care.

Read More